WO2026088052 - PROCESS FOR THE PURIFICATION OF CANNABIDIOL FROM HERBAL MATERIAL

National phase entry is expected:
Publication Number WO/2026/088052
Publication Date 30.04.2026
International Application No. PCT/IB2025/060679
International Filing Date 20.10.2025
Title **
[English] PROCESS FOR THE PURIFICATION OF CANNABIDIOL FROM HERBAL MATERIAL
[French] PROCÉDÉ DE PURIFICATION DE CANNABIDIOL À PARTIR D'UN MATÉRIAU À BASE D'HERBES
Applicants **
A2W PHARMA LIMITED
Inventors
GURRADO, Domenico
HU, Fayuan
Priority Data
18/927,554   25.10.2024   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2026
EPO Filing, Examination, Granting8107
Japan Filing, Examination, Granting2154
South Korea Filing, Examination, Granting2066
USA Filing, Examination, Granting5940
MasterCard Visa
Total: 20,293
Contact Us
Abstract[English] The present invention relates to a process for purifying cannabinoids, specifically cannabidiol, in a substantially pure form from herbal material. This process involves a sequence of purification steps including winterization, co-crystallization, dissociation, decarboxylation, and crystallization. Cannabidiol is purified from an extract of herbal material containing approximately 50-70% cannabidiolic acid (CBDA) and 10-20% cannabidiol (CBD), along with other cannabinoids. The substantially pure form of cannabidiol can be used in medicaments for treating various diseases or conditions. The invention also relates to co-crystals of L-proline and cannabidiolic acid and their use in obtaining substantially pure cannabidiol free from tetrahydrocannabinol (THC).[French] La présente invention concerne un procédé de purification de cannabinoïdes, en particulier de cannabidiol, sous une forme sensiblement pure à partir d'un matériau à base d'herbes. Ce procédé implique une séquence d'étapes de purification comprenant la frigélisation, la co-cristallisation, la dissociation, la décarboxylation et la cristallisation. Le cannabidiol est purifié à partir d'un extrait de matière végétale contenant environ 50 à 70% d'acide cannabidiolique (CBDA) et 10 à 20% de cannabidiol (CBD), conjointement avec d'autres cannabinoïdes. La forme sensiblement pure de cannabidiol peut être utilisée dans des médicaments pour le traitement de diverses maladies ou affections. L'invention concerne également des co-cristaux de L-proline et d'acide cannabidiolique et leur utilisation dans l'obtention de cannabidiol sensiblement pur exempt de tétrahydrocannabinol (THC).